Emerging Monoclonal Antibody Therapy for the Treatment of Acute Lymphoblastic Leukemia
Tareq Abuasab,1 Jacob Rowe,1– 3 Ariella Tvito1 1Department of Hematology, Shaare Zedek Medical Center, Jerusalem, Israel; 2Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; 3Bruce Rappaport Faculty of Medicine, Technion, Israel Institute of Technolog...
Guardado en:
Autores principales: | Abuasab T, Rowe J, Tvito A |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/128a4b37bd1b4581b134c475acda3442 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Blinatumomab for the Treatment of Adult B-Cell Acute Lymphoblastic Leukemia: Toward a New Era of Targeted Immunotherapy
por: Franquiz MJ, et al.
Publicado: (2020) -
Recent advances in the biology and treatment of B-cell acute lymphoblastic leukemia
por: Hefazi M, et al.
Publicado: (2018) -
FEATURES OF IMMUNE CELLS IN ACUTE LYMPHOBLASTIC LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014) -
Profound leukemia cutis in a patient with relapsed T-cell acute lymphoblastic leukemia
por: Ambika Nohria, BA, et al.
Publicado: (2021) -
STAGE-DEPENDENT IMMUNOPATHOGENETIC FEATURES OF ACUTE NONLYMPHOBLASTIC AND ACUTE LYMPHOBLASTIC LEUKEMIA
por: O. V. Smirnova, et al.
Publicado: (2014)